Gamco Investors INC. ET AL Purchases 11,900 Shares of Olink Holding AB (publ) (NASDAQ:OLK)

Gamco Investors INC. ET AL raised its position in shares of Olink Holding AB (publ) (NASDAQ:OLK) by 7.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 179,400 shares of the company’s stock after acquiring an additional 11,900 shares during the quarter. Gamco Investors INC. ET AL owned about 0.14% of Olink Holding AB (publ) worth $4,218,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of OLK. Assetmark Inc. boosted its position in shares of Olink Holding AB (publ) by 30.5% during the 4th quarter. Assetmark Inc. now owns 2,874 shares of the company’s stock worth $72,000 after purchasing an additional 672 shares in the last quarter. PenderFund Capital Management Ltd. bought a new position in shares of Olink Holding AB (publ) during the 4th quarter worth about $393,000. Ardent Capital Management Inc. bought a new position in shares of Olink Holding AB (publ) during the 1st quarter worth about $470,000. Wolverine Asset Management LLC bought a new position in shares of Olink Holding AB (publ) during the 4th quarter worth about $692,000. Finally, Virtu Financial LLC acquired a new stake in shares of Olink Holding AB (publ) in the 4th quarter worth about $1,061,000. Institutional investors own 30.19% of the company’s stock.

Olink Holding AB (publ) Price Performance

Shares of OLK remained flat at $26.08 on Friday. 2,206 shares of the company were exchanged, compared to its average volume of 633,228. Olink Holding AB has a 12 month low of $14.10 and a 12 month high of $26.09. The firm has a market cap of $3.24 billion, a PE ratio of -96.59 and a beta of 0.52. The company has a fifty day moving average of $25.20 and a two-hundred day moving average of $24.22.

Olink Holding AB (publ) (NASDAQ:OLK) last posted its earnings results on Monday, May 13th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Olink Holding AB (publ) had a negative return on equity of 7.07% and a negative net margin of 19.72%. The business had revenue of $28.75 million during the quarter, compared to analyst estimates of $31.29 million. Equities research analysts forecast that Olink Holding AB will post -0.19 EPS for the current fiscal year.

About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.